Ellis, CR; Kruhlak, NL; Kim, MT; Hawkins, EG; Stavitskaya, L. Predicting opioid receptor binding affinity of pharmacologically unclassified designer substances using molecular docking. PLOS ONE, 24 May 2018, 13 (5), e0197734. 5.5 MB. https://doi.org/10.1371/journal.pone.0197734 #Propoxyphene
Newby, NR; Hughes, RB. Identification of dextropropoxyphene and its diastereoisomers. J. Forensic Sci., 1 Jul 1980, 25 (3), 646–654. 593 kB. https://doi.org/10.1520/JFS11269J #Propoxyphene NMR,IR,TLC,other
Angelos, SA; Janovsky, TJ; Raney, JK. The identification and quantitation of pharmaceutical preparations by nuclear magnetic resonance spectroscopy. J. Forensic Sci., 1 Mar 1991, 36 (2), 358–365. 383 kB. https://doi.org/10.1520/JFS13038J #Propoxyphene NMR
Johnson, H. Quantitative stereo-structure activity relationships I. Opiate receptor binding. In QuaSAR: Quantitative Structure Activity Relationships of Analgesics, Narcotic Antagonists, and Hallucinogens. NIDA Research Monograph 22; Barnett, G; Trsic, M; Willette, RE, Eds., U.S. Department of Health and Human Services, National Institute of Health, U.S. Government Printing Office, Washington, DC, 1 Jan 1978; Vol. 22, pp 146–158. 685 kB.
Phelan, CP. Quantitation and enantiomeric determination of propoxyphene using capillary zone electrophoresis. Microgram J., 1 Jan 2005, 3 (1–2), 31–38. 132 kB. #Propoxyphene other